Regarding actuarial late effect analyses: Bentzen et al., IJROBP 32:1531- 1534; 1995 and Caplan et al., IJROBP 32:1547; 1995 [1]

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 1, 1996, Pages 197-

  Denham, J W ^a   Hamilton, C S ^a   O'Brien, P ^a   Caplan, R J ^a   Pajak, T F ^a   Cox, J D ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DIAGNOSIS; LETTER; MYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR;

EID: 0029872167     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)85032-2     Document Type: Letter

References (3)

1. S.M. Bentzen M. Vaeth D.E. Pedersen J. Overgaard Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment … Now! Intl. J. Radiat. Oncol. Biol. Phys. 32 5 1995 1531 1534
2. a R.J. Caplan T.F. Pajak J.D. Cox In response to Bentzen et al. IJROBP 32 5 1995 1531 1534
3. b R.J. Caplan T.F. Pajak J.D. Cox Intl. J. Radiat. Oncol. Biol. Phys. 32 5 1995 1547